The Lancet Gastroenterology & Hepatology in conversation with
80 episodes - English - Latest episode: 14 days ago -Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
A new drug for short bowel syndrome
April 05, 2019 22:30 - 11 minutes - 7.03 MBDr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Eosinophilic oesophagitis endotype classification
March 09, 2019 15:00 - 9 minutes - 6.78 MBMarc Rothenberg joins The Lancet Gastroenterology & Hepatology to talk about eosinophilic oesophagitis endotype classification. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Acute hepatitis C
March 08, 2019 07:30 - 6 minutes - 4.53 MBBart Rijnders discusses his recent work on the treatment of people with acute hepatitis C. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Epidemiology of chronic liver disease
February 08, 2019 07:30 - 8 minutes - 6.03 MBJennifer Flemming talks with The Lancet Gastroenterology & Hepatology about recent developments in the field of chronic liver disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Viral hepatitis in migrant populations
December 07, 2018 19:00 - 4 minutes - 3.03 MBGraham Foster speaks with The Lancet Gastroenterology & Hepatology about his recent work on incentivising and supporting primary-care physicians to increase hepatitis screenings of migrant populations. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
DAA treatment for hepatitis C among people who inject drugs
October 25, 2018 23:00 - 10 minutes - 7.53 MBBehzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Pancreatic cancer treatment
September 06, 2018 06:30 - 8 minutes - 6.03 MBMichele Reni speaks with The Lancet Gastroenterology & Hepatology about the PAXG regimen for treatment of pancreatic cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
UDCA Response Score
August 10, 2018 05:00 - 9 minutes - 6.78 MBMarco Carbone talks to The Lancet Gastroenterology & Hepatology about predicting treatment response for patients with primary biliary cholangitis Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Global prevalence, treatment, and prevention of hepatitis B virus infection
May 03, 2018 06:30 - 13 minutes - 9.03 MBHomie Razavi and Devin Razavi-Shearer join The Lancet Gastroenterology & Hepatology to discuss their HBV modelling study. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Neoplasia detection in ulcerative colitis
April 06, 2018 15:00 - 8 minutes - 6.03 MBJasper Vleugels joins The Lancet Gastroenterology and Hepatology to discuss the results of the FIND-UC trial. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Functional dyspepsia
March 08, 2018 07:30 - 10 minutes - 7.53 MBImran Aziz discusses his paper on functional dyspepsia, which is published in the April issue of The Lancet Gastroenterology & Hepatology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Can DAA therapy for HCV reactivate HBV in coinfected patients?
February 08, 2018 20:00 - 6 minutes - 4.53 MBIn this Lancet Gastroenterology & Hepatology podcast, Johannes Vermehren discusses the risks of Hepatitis B reactivation in coinfected patients receiving treatment for Hepatitis C. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018
January 13, 2018 15:30 - 18 minutes - 12.8 MBSandra Andorf and Kari Nadeau discuss their work on anti-IgE treatment with oral immunotherapy in multifood allergic participants. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018
December 09, 2017 07:30 - 6 minutes - 4.53 MBPeter Johnsen discusses his paper on faecal transplantation as a treatment for IBS. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017
November 09, 2017 07:30 - 12 minutes - 8.28 MBJeffrey Hyams discusses the PROTECT study, which looks at outcomes in paediatric ulcerative colitis. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017
September 02, 2017 06:30 - 21 minutes - 15 MBYeng Ang and James Britton discuss setting research priorities for future work in Barrett's oesophagus and gastro-oesophageal reflux disease Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017
August 19, 2017 22:30 - 9 minutes - 6.78 MBAdrian Miranda talks about his work on using neurostimulation as a method for addressing abdominal pain-related functional gastrointestinal disorders in children. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017
August 03, 2017 06:30 - 9 minutes - 6.78 MBMark Fox talks about development of a solid meal test for diagnosing oesophageal motility disorders. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017
July 06, 2017 14:30 - 6 minutes - 4.53 MBFederico Aucejo talks about his HALT-HCC score, which assesses risk for patients with hepatocellular carcinoma awaiting liver transplant. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017
June 08, 2017 06:30 - 13 minutes - 9.03 MBNick Sheron covers the public health and clinical problems presented by alcohol-related liver disease, and discusses what can be achieved with early intervention. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017
May 05, 2017 07:00 - 12 minutes - 8.28 MBJames Lindsay discusses his article on autologous stem-cell transplantation in treatment-refractory Crohn's disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017
April 06, 2017 06:30 - 6 minutes - 4.53 MBLeo Katsidzira talks about the epidemiology of colorectal cancer in sub-Saharan Africa. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Treatment of an appendix mass in children: The Lancet Gastroenterology & Hepatology: March 8, 2017
March 08, 2017 16:00 - 8 minutes - 6.03 MBAs part of The Lancet Gastroenterology & Hepatology’s April issue, Nigel Hall discusses the CHINA trial of observation versus interval appendicectomy for children with an appendix mass. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017
February 09, 2017 23:30 - 12 minutes - 8.28 MBNaveed Janjua discusses a study looking at the risk factors associated with hepatitis C reinfection and means to prevent it. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017
January 12, 2017 15:30 - 10 minutes - 7.53 MBMagnus Simrén comprehensively reviews treatments and therapies for irritable bowel syndrome. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Barrett's oesophagus: The Lancet Gastroenterology & Hepatology: Jan 2017
December 10, 2016 07:30 - 12 minutes - 8.28 MBRebecca Fitzgerald discusses her paper on risk stratification for patients with Barrett's oesophagus. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Inflammatory bowel disease: The Lancet Gastroenterology & Hepatology: December issue
November 09, 2016 08:00 - 15 minutes - 10.5 MBGil Kaplan discusses the rise of IBD in countries that don't have a history of the disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Liver fibrosis screening: The Lancet Gastroenterology & Hepatology: October 12, 2016
October 13, 2016 14:30 - 9 minutes - 6.78 MBPere Ginès from the Liver Unit at the Hospital Clinic in Barcelona, Spain, discusses a Viewpoint for liver fibrosis screening in the general population. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Migraine and GI disorders: The Lancet Gastroenterology & Hepatology: September 7, 2016
September 08, 2016 22:30 - 7 minutes - 4.9 MBLuigi Titomanlio from INSERM in France discusses a case control study investigating an association between functional gastrointestinal disorders and migraine. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Reducing population alcohol consumption: The Lancet Gastroenterology & Hepatology: August 10, 2016
August 11, 2016 22:30 - 18 minutes - 12.8 MBIn the first podcast for The Lancet Gastroenterology & Hepatology, Editor Rob Brierley outlines the scope of the new journal, and Jürgen Rehm discusses public health priorities for reducing population alcohol consumption. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv